²é¿´: 1712  |  »Ø¸´: 2

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

[½»Á÷] Ìì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕÔÀö½ÌÊÚ¿ÎÌâ×齲ʦ¡¢²©ºó¼°¿ÆÑÐÖúÀíÕÐÆ¸

¾ßÌ幤×÷µØµã:
Ìì½òÊÐºÍÆ½ÇøÆøÏǫ́·22ºÅÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº
н½ð:
ÔÂн°ËǧÖÁÒ»Íò
ѧÀúºÍÑо¿·½Ïò:
ÉúÎҽѧ¡¢Ò©Ñ§µÈ
ÕÐÆ¸¸Úλ:
½²Ê¦/²©ºó/¿ÆÑÐÖúÀí
¹«Ë¾Ãû³Æ:
Ìì½òÒ½¿Æ´óѧ
ÁªÏµ·½Ê½:
shzhaoli@tmu.edu.cn

¿ÎÌâ×é½éÉÜ
       ÕÔÀö½ÌÊÚΪÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧϵ½ÌÊÚ£¬Ìì½òÊÐÌØÆ¸½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£
       ¿ÎÌâ×鳤ÆÚÖÂÁ¦ÓÚÁ˽âÏÂÇðÄÔ-´¹Ì壬¼××´ÏÙ£¬ÈéÏÙµÈÉñ¾­ÄÚ·ÖÃÚ»·Â·ÖÐµÄÆ÷¹Ù·¢Óý£¬²¢ÒÔ´ËÍÆ½ø¶ÔÏà¹Ø¼²²¡ºÍ°©Ö¢·¢Éú»úÖÆµÄÀí½â¡£ÀûÓÃת»ùÒòСÊó¹¹½¨¸÷ÖÖÌù½üÁÙ´²ÉúÀí¼²²¡ºÍ°©Ö¢µÄ¶¯Îï¼²²¡Ä£ÐÍ£»½Òʾ²¢×·×ÙÆ÷¹Ù·¢ÓýºÍÖ×Áö·¢ÉúµÄ¹Ø¼üÆðʼϸ°ûµÄ£»ÒÔǰÆÚ·Ö×Ó»úÖÆÍÚ¾òºÍÄÉÃ×°ÐÏòÒ©ÎïµÄ¿ª·¢ÓëµÝËÍΪ»ù´¡£¬Îª°©Ö¢ÖÎÁÆÌرðÊÇÄÑÖÎÐÔ¡¢×ªÒÆÐÔ°©Ö¢µÄÖÎÁÆÌṩ°ÐÏòÐÔÓëÓÐЧÐԸߡ¢¸±×÷ÓÃСµÄÖÎÁƲßÂÔ¡£
¿ÎÌâ×é³É¹û£º
       ·¢±íÔÚMolecular Cell¡¢Developmental Cell¡¢Nature Communications¡¢Development¡¢Oncogene¡¢Journal of Bone and Mineral Research¡¢ACS NanoµÈÔÓÖ¾20ÓàÆª¡£
1. Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L. (2024) Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.Nat Commun. 15(1):4108.
2. Zhang P, Guan L, Sun W, Zhang Y, Du Y, Yuan S, Cao X, Yu Z, Jia Q, Zheng X, Meng Z, Li X, Zhao L.(2024) Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma. Clin Transl Med. 14(5):e1694.
3. Su Y, Luo Y, Zhang P, Lin H, Pu W, Zhang H, Wang H, Hao Y, Xiao Y, Zhang X, Wei X, Nie S,Zhang K, Fu Q, Chen H, Huang N, Ren Y, Wu M, Chow BKC, Chen X, Jin W, Wang F, Zhao L*, Rao F*. (2023) Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis. Mol Cell. 83(13):2316-2331.e7.
4¡¢Zhang P, Guan H, Yuan S, Cheng H, Zhang Z, Zheng J, Yu Y, Meng Z, Zheng X, Zhao L*. (2022) Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. Nat Commun. 13(1):1588
5¡¢Yuan S, Zhang P, Wen L, Jia S, Wu Y, Zhang Z, Guan L, Yu Z, Zhao L*. (2021) miR-22 promotes stem cell traits via activating Wnt/¦Â-catenin signaling in cutaneous squamous cell carcinoma. Oncogene. 40(39):5799-5813
6¡¢Bi X, Lou P, Song Y, Sheng X, Liu R, Deng M, Yang X, Li G, Zhang B, Xue L, Liu Z, Plikus M, Ren F, Gao S, Yuan S, Zhang H, Jiao B, Zhao L*, Yu Z* (2021) Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene. 40(29):4832-4845
ÕÐÆ¸¸Úλ¼°ÒªÇó£º
1. ¿ÆÑÐÖúÀí1Ãû£ºÄêÁä¡Ü30ÖÜË꣬¾ßÓÐ˶ʿÑо¿Éú¼°ÒÔÉÏѧÀúºÍѧ룬ÉúÎҽѧ¡¢Ò©Ñ§µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡ÊìÁ·ÕÆÎÕϸ°ûÅàÑø¡¢»ù±¾µÄÉú»¯ºÍ·Ö×ÓÉúÎïѧʵÑé¼¼ÄÜ£¬µÚ1×÷Õß·¢±íÓÐSCIÂÛÎÄÕßÓÅÏÈ¡£
2. ½²Ê¦1Ãû£¬²©Ê¿ºó1Ãû£ºÄêÁä¡Ü35ÖÜË꣬¾ßÓв©Ê¿Ñо¿ÉúѧÀúºÍѧ룬Ö×Áö¡¢ÌÇÖ¬´úлºÍ±í¹ÛÒÅ´«µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡È¡µÃ½ÏºÃµÄÑо¿³É¹û£¨ÒÔµÚ1×÷Õß·¢±íQ1ÇøSCIÂÛÎÄÕßÓÅÏÈ£©²¢ÇҾ߱¸Á¼ºÃµÄ·¢Õ¹Ç±Á¦£»¾ßÓжÀÁ¢µÄ¿ÎÌâÉè¼ÆÄÜÁ¦ºÍÔúʵµÄʵÑé²Ù×÷ÄÜÁ¦£¬Äܹ»ÔÚPIµÄÖ¸µ¼Ï¶ÀÁ¢Õ¹¿ªÑо¿¹¤×÷£¬²¢²ÎÓëÑо¿ÉúµÄÖ¸µ¼¹¤×÷¡£

н³ê´ýÓö£º
1. ´ýÓö²ÎÕÕÌì½òÒ½¿Æ´óѧÏà¹ØÈËÊÂÕþ²ß²¢´ÓÓÅ¡£
2. Ìṩ¿ÆÑÐÖ¸µ¼£¬²Î¼Ó¹úÄÚÍâѧÊõ»áÒéµÄ»ú»á£¬È«Á¦Ö§³ÖÉêÇë¸÷ÖÖ»ù½ðºÍÈ˲ÅÏîÄ¿¡£
3. ¿ÆÑÐÖúÀíÒµÎñÊìÁ·Õß¿ÉÍÆ¼ö¼ÌÐø¶Á²©

»¶Ó­Ö¾È¤ÏàͶ¡¢ÈȰ®¿ÆÑС¢Çڷܿ̿àµÄ¿ÆÑÐÖúÀí¡¢²©Ê¿ºóºÍ½²Ê¦Ó¦Æ¸Õß¼ÓÈë¿ÎÌâ×飡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ðÔÀÔÀÔÀÒ©

гæ (³õÈëÎÄ̳)

½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð
2Â¥2025-02-26 10:37:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by ½ðÔÀÔÀÔÀÒ© at 2025-02-26 10:37:19
½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð

µ±È»¿ÉÒÔѽ
3Â¥2025-04-16 17:19:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÓÐÈË¿´µ½ÎҵĶú» µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 DpSrDtM079iu 2026-08-22 4/200 2026-08-23 01:04 by OEbVnUOu01ol
[¿¼²©] ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 DpSrDtM079iu 2026-08-22 3/150 2026-08-23 00:55 by OEbVnUOu01ol
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼± +3 2JOx3r2CYEgw 2026-08-22 6/300 2026-08-23 00:52 by OEbVnUOu01ol
[¿¼²©] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼± +3 2JOx3r2CYEgw 2026-08-21 8/400 2026-08-23 00:28 by OEbVnUOu01ol
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.54,¿ÆÄ¿È«,¿ÉÙ¤¼± +4 QTy3jDtz1uLt 2026-08-21 10/500 2026-08-22 23:42 by OEbVnUOu01ol
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 2JOx3r2CYEgw 2026-08-22 3/150 2026-08-22 22:03 by OEbVnUOu01ol
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼± +3 2JOx3r2CYEgw 2026-08-22 3/150 2026-08-22 22:03 by OEbVnUOu01ol
[»ù½ðÉêÇë] ·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë +3 zjuhero 2026-08-22 4/200 2026-08-22 20:02 by mycsru
[½Ìʦ֮¼Ò] Ìø²ÛºóÔÚÑÐÏîÄ¿Ôõô°ì£¿ +3 ¼òµ¥»¯xn 2026-08-22 7/350 2026-08-22 19:46 by ¼òµ¥»¯xn
[»ù½ðÉêÇë] Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ +24 yaoyewhu2008 2026-08-20 26/1300 2026-08-22 17:43 by kammury
[½Ìʦ֮¼Ò] ÊÛÒ»ÇøSCIÎÄÕÂT0P£¬ÎÒ:8O.551.O54,¿ÆÄ¿È«,¿ÉÊ®¼± +4 2JOx3r2CYEgw 2026-08-21 4/200 2026-08-22 16:52 by sunzitan
[»ù½ðÉêÇë] ½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã +10 kulium 2026-08-21 13/650 2026-08-21 21:58 by alongwaytogo
[»ù½ðÉêÇë] ½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û +16 ҽѧÀÏÄк¢ 2026-08-20 20/1000 2026-08-21 21:13 by Ldrop2023
[»ù½ðÉêÇë] ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡ +11 ´óƼ1987 2026-08-20 13/650 2026-08-21 14:48 by 20120902066
[»ù½ðÉêÇë] ¸Ð¾õÊÇÏÂÖܷŰñÁË +7 angus9576 2026-08-17 12/600 2026-08-21 13:38 by weiyin
[»ù½ðÉêÇë] ÎÒÃæÉÏÍêµ°ÁË +7 ÇÒÌý»¢Ð¥ 2026-08-20 8/400 2026-08-21 12:31 by ¿á¿áÄ«¾µ
[»ù½ðÉêÇë] ½ñÌì·Å°ñûϷÁ衃 +9 yuleib84 2026-08-19 11/550 2026-08-21 10:06 by gltch
[»ù½ðÉêÇë] »ù½ð°¡»ù½ð +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
[»ù½ðÉêÇë] ÅóÓÑȦ¿´µ½µÄ +6 wangzilk 2026-08-18 8/400 2026-08-19 10:55 by Haru815
[»ù½ðÉêÇë] ½ñÌìά»¤ÏµÍ³Î¬»¤ ×£ËùÓÐÈË ¸ßÖÐ +8 gjjjzhong 2026-08-18 9/450 2026-08-18 13:01 by ¼ÒÓëÔ¶·½
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û